Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
10 drugs in development
By Therapeutic Area
top 6
R&D Momentum
92/100
Pipeline Velocity
71/100
Trial Completion Rate
71/100
Pipeline Concentration
22/100
Pipeline Freshness
79/100
Strategic Signals
Activity
Last 14 days
Trifecta-Lung cfDNA-MMDx Study: Comparing the Dd-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM): A Pilot Randomized Trial
Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis
Central Blood Volume Shifts in Healthy Adults With Varying Levels of Fitness: Effects on Lung Diffusing Capacity
Innovative Approaches to the Lack of Evidence-based Dietary Protein Requirements for Patients With Cancer
A Preliminary Human Study on Bioavailability and Efficacy of Bioactive Peptide IRW in Egg White Hydrolysate
Alberta Back Care Pathway (ABCp)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)